NEW YORK, Aug. 7 – Genomica Corporation's revenue jumped 17 percent to $464,000 for the second quarter 2001, compared to $396,000 recorded in the year-ago period, the company said on Tuesday.

The Boulder, Colo.-based company attributed the revenue rise to licensing fees from its LinkMapper software and consulting fees from its alliance with Applied Biosystems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.